The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCS.L Regulatory News (SCS)

  • There is currently no data for SCS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - ScS Group PLC

17 Jan 2024 11:20

RNS Number : 0264A
GoldmanSachs International
17 January 2024
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

SCS GROUP PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

CEREZZOLA LIMITED (A WHOLLY-OWNED SUBSIDIARY OF POLTRONESOFA S.P.A.)

(d) Date dealing undertaken:

16 January 2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

0.1p ordinary

Purchases

10,000

2.6800 GBP

2.6800 GBP

0.1p ordinary

Sales

10,000

2.6800 GBP

2.6800 GBP

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising / exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

17 January 2024

Contact name:

Papa Lette and Andrzej Szyszka

Telephone number:

+33(1) 4212 1459 / +48(22) 317 4817

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERQKOBDDBKDCDD
Date   Source Headline
18th Jun 20204:36 pmRNSPrice Monitoring Extension
26th May 20207:00 amRNSREOPENING & LIQUIDITY UPDATE
6th May 20202:42 pmRNSNotification of Major Holdings
15th Apr 20203:36 pmRNSDirector/PDMR Shareholding
9th Apr 20204:41 pmRNSSecond Price Monitoring Extn
9th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20207:00 amRNSINTERIM DIVIDEND AND BOARD UPDATE
2nd Apr 20204:40 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:36 pmRNSPrice Monitoring Extension
31st Mar 202012:08 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
27th Mar 20204:40 pmRNSSecond Price Monitoring Extn
27th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSUPDATE ON IMPACT OF COVID-19
20th Mar 20207:00 amRNSInterim Results
17th Mar 20204:37 pmRNSPrice Monitoring Extension
17th Mar 20207:00 amRNSTRADING UPDATE
16th Mar 20204:43 pmRNSSecond Price Monitoring Extn
16th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Feb 20207:00 amRNSNotification of Major Holdings
11th Feb 202010:30 amRNSDirectorate Change
11th Feb 202010:03 amRNSNotification of PDMR Transaction
11th Feb 20207:00 amRNSResult of Accelerated Bookbuild in ScS Group plc
10th Feb 20204:41 pmRNSSecond Price Monitoring Extn
10th Feb 20204:35 pmRNSPrice Monitoring Extension
10th Feb 20204:35 pmRNSProposed Accelerated Bookbuild in ScS Group plc
29th Jan 20207:00 amRNSHalf Year Trading Update & Board Change
6th Dec 201910:28 amRNSDirector/PDMR Shareholding
4th Dec 201910:55 amRNSDirector/PDMR Shareholding
27th Nov 20194:53 pmRNSResult of AGM
21st Nov 20194:52 pmRNSNotification of Major Holdings
8th Nov 20193:26 pmRNSNOTIFICATION OF MAJOR HOLDINGS
7th Nov 201911:37 amRNSNotification of PDMR Transaction
6th Nov 20192:55 pmRNSPurchase of Shares
6th Nov 20197:15 amRNSPurchase of Own Shares
6th Nov 20197:00 amRNSResult of Accelerated Bookbuild in ScS Group plc
5th Nov 20194:39 pmRNSProposed Share Buyback
5th Nov 20194:35 pmRNSProposed Accelerated Bookbuild in ScS Group plc
24th Oct 20197:00 amRNSAnnual Report and Notice of AGM
18th Oct 201910:50 amRNSVesting of 2017 LTIP awards and PDMR notifications
14th Oct 20193:30 pmRNSGrant of Awards
14th Oct 20197:00 amRNSPurchase of Shares by Employee Benefit Trust
11th Oct 201910:40 amRNSPROPOSED FINAL DIVIDEND TIMETABLE
9th Oct 20197:00 amRNSPurchase of Shares by Employee Benefit Trust
1st Oct 20197:00 amRNSPreliminary Results
2nd Sep 20191:59 pmRNSPurchase of Shares by Employee Benefit Trust
21st Aug 20195:13 pmRNSPurchase of Shares by Employee Benefit Trust
21st Aug 20193:25 pmRNSNotification of Major Holdings
9th Aug 20194:17 pmRNSPurchase of Shares by Employee Benefit Trust
1st Aug 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.